Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Idebenone for Primary Progressive Multiple Sclerosis

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Neurological Disorders and Stroke (NINDS) )
ClinicalTrials.gov Identifier:
NCT01854359
First received: May 11, 2013
Last updated: October 12, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: August 2019
  Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)